Advertisement
Screener

Vivo Capital, LLC Historic Quarter Change: USA Other Stocks, New

Vivo Capital, LLC historic quarter change: USA Other Stocks, New

In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 12 quarters from 2016-03-31 to 2026-06-30, Vivo Capital, LLC opened 7 positions, added to 5, reduced 8 and sold out of 16.

  • Q2 2025: Stock Sinovac Biotech Ltd.; Country of operation —; Class SHS; Shares before 0.
  • Q1 2024: Stock Sinovac Biotech Ltd.; Country of operation —; Class SHS; Shares before 0.
  • Q1 2024: Stock Regulus Therapeutics Inc; Country of operation United States; Class Common; Shares before 0.
  • Q3 2016: Stock CoLucid Pharmaceuticals, Inc.; Country of operation —; Class Common; Shares before 0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1674712), 12 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-20); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-13); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-12); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-13); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-13); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-04-22); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2016-03-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2025Sinovac Biotech Ltd.
CUSIP P8696W104
SHS05,903,000+5,903,000$0$38,192,410+$38,192,4102025-08-14
Q1 2024Sinovac Biotech Ltd.
CUSIP P8696W104
SHS011,800,000+11,800,000$0$76,346,000+$76,346,0002024-04-22
Q1 2024Regulus Therapeutics Inc
CUSIP 75915K309
United StatesCommon05,000,000+5,000,000$0$14,400,000+$14,400,0002024-04-22
Q3 2016CoLucid Pharmaceuticals, Inc.
CUSIP 19716T101
Common0225,000+225,000$0$8,584,000+$8,584,0002016-11-14
Q3 2016Foamix Pharmaceuticals Ltd.
CUSIP M46135105
Common0855,000+855,000$0$7,917,000+$7,917,0002016-11-14
Q2 2016Aimmune Therapeutics, Inc.
CUSIP 00900T107
Common0763,009+763,009$0$8,256,000+$8,256,0002016-08-15
Q2 2016Minerva Neurosciences, Inc.
CUSIP 603380106
Common0200,000+200,000$0$2,042,000+$2,042,0002016-08-15

Similar Firms

Firm NameCountry13F ValueHoldings
DT Investment Partners, LLCUnited States$1.202B555
SPX Gestao de Recursos LtdaBrazil$1.204B82
a16z Perennial Management, L.P.United States$1.204B152
Danmarks NationalbankDenmark$1.205B1
W.G. Shaheen & Associates DBA Whitney & CoUnited States$1.201B175
JNBA Financial AdvisorsUnited States$1.201B819
Guardian Partners Inc.Canada$1.200B192
Amplius Wealth Advisors, LLCUnited States$1.200B175
Richard C. Young & CO., LTD.United States$1.207B93
Anchor Investment Management, LLCUnited States$1.199B1,067